Celgene Wants Barr's Antitrust Claims Put On Hold
Celgene Corp. is asking a New Jersey court to put the antitrust and unfair competition counterclaims Barr Laboratories Inc. lodged in response to Celgene's patent infringement complaint over the cancer drug...To view the full article, register now.
Already a subscriber? Click here to view full article